Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-C motif chemokine ligand 1 (XCL1) is a unique member of the chemokine family, notable for possessing a single disulfide bond and the ability to spontaneously switch between two different protein folds—one that activates its specific G protein-coupled receptor (XCR1), and another that binds glycosaminoglycans and displays antimicrobial activity. XCL1 is predominantly secreted by activated CD8+ T cells and natural killer (NK) cells and plays a key role in directing the migration and activation of conventional dendritic cells subtype 1 (cDC1), a process vital to cross-presentation and activation of cytotoxic lymphocytes against tumors and infection. The XCL1–XCR1 signaling axis is of significant interest in cancer immunotherapy, vaccine development, and broader immune modulation. XCL1 is classified as a metamorphic protein due to its structural versatility, which is rare in biology and critical for its multifaceted biological functions[1][2][3][4][5]
Binding to XCR1 and triggering downstream G protein-mediated signaling. Modulation of antigen presentation in dendritic cells for immunotherapy or vaccine enhancement[1][3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-C motif chemokine ligand 1 (XCL1).